Universitätsklinikum Frankfurt, Klinik für Kinder- und Jugendmedizin, Schwerpunkt Neurologie, Neurometabolik und Prävention
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kornblum, Cornelia
STRIDE, NCT04535609 / 2020-002855-40: An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients

Completed
2
213
Europe, Canada, US, RoW
Mavodelpar, REN001, Placebo
Reneo Pharma Ltd
Primary Mitochondrial Myopathy
09/23
10/23
PMD-OPTION, NCT05972954 / 2022-003307-16: OMT-28 in Patients With Primary Mitochondrial Disease (PMD)

Active, not recruiting
2
32
Europe
OMT-28
Omeicos Therapeutics GmbH, OMEICOS Therapeutics GmbH
Primary Mitochondrial Disease
03/25
06/25
NCT05554835: Global Registry and Natural History Study for Mitochondrial Disorders

Recruiting
N/A
6000
Europe
LMU Klinikum, European Commission, German Federal Ministry of Education and Research, University of Pisa
Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO, SCAE, NARP Syndrome, MELAS Syndrome, MERRF Syndrome, Coenzyme Q10 Deficiency, LHON, MNGIE, MIRAS, Barth Syndrome, MDS, Mitochondrial Myopathies, Leigh Syndrome, Pearson Syndrome, CPEO
12/40
12/40
Kieslich, Matthias
NCT05554835: Global Registry and Natural History Study for Mitochondrial Disorders

Recruiting
N/A
6000
Europe
LMU Klinikum, European Commission, German Federal Ministry of Education and Research, University of Pisa
Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO, SCAE, NARP Syndrome, MELAS Syndrome, MERRF Syndrome, Coenzyme Q10 Deficiency, LHON, MNGIE, MIRAS, Barth Syndrome, MDS, Mitochondrial Myopathies, Leigh Syndrome, Pearson Syndrome, CPEO
12/40
12/40

Download Options